Breakthrough pancreatic cancer drug approved by the FDA - PhillyVoice
Breakthrough pancreatic cancer drug approved by the FDA PhillyVoice
Онкология
Лечение и препараты
447 материалов по теме, собраны автоматически из проверенных источников
🎗️
Онкология
FDA approves pancreatic cancer drug that extends patients’ lives - The Washington Post
FDA approves pancreatic cancer drug that extends patients’ lives The Washington Post
Онкология
В Аделаиде изучают точную лучевую терапию рака мозга - UA.NEWS
В Аделаиде изучают точную лучевую терапию рака мозга UA.NEWS
Онкология
Inherited genetic variants help identify patients at higher risk of aggressive therapy-related blood cancers
Some patients develop aggressive blood cancers years after receiving chemotherapy or radiotherapy for a previous cancer. These conditions, known as therapy-related myeloid neoplasms (t-MN), are currently classified mainly according to a patient's treatment history, even though their clinical course can vary…
Онкология
New drug poised to transform pancreatic cancer care after FDA approval - WXYZ Channel 7
New drug poised to transform pancreatic cancer care after FDA approval WXYZ Channel 7
🎗️
Онкология
FDA approves life-extending pancreatic cancer drug Rasonque - USA Today
FDA approves life-extending pancreatic cancer drug Rasonque USA Today
Онкология
FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival - The Conversation
FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival The Conversation
🎗️
Онкология
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
Онкология
FDA approves breakthrough pancreatic cancer drug proven to extend survival - Washington Examiner
FDA approves breakthrough pancreatic cancer drug proven to extend survival Washington Examiner
Онкология
Rasonque earns FDA approval for pancreatic cancer
The FDA has approved a first-in-class targeted therapy for adults with metastatic pancreatic adenocarcinoma. Daraxonrasib (Rasonque, Revolution Medicines), an RAS inhibitor, received approval for patients who previously received at least one prior line of systemic therapy and are not candidates for multiagent systemic…
Онкология
FDA Approves Rasonque™ (daraxonrasib) - Pancreatic Cancer Action Network
FDA Approves Rasonque™ (daraxonrasib) Pancreatic Cancer Action Network
Онкология
FDA approves ‘game-changing’ pancreatic cancer drug - NBC News
FDA approves ‘game-changing’ pancreatic cancer drug NBC News
🎗️
Онкология
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease - WSJ
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJ
Онкология
FDA approves breakthrough drug to treat advanced pancreatic cancer - ABC News - Breaking News, Latest News and Videos
FDA approves breakthrough drug to treat advanced pancreatic cancer ABC News - Breaking News, Latest News and Videos
Онкология
FDA approves first-of-its-kind treatment for most common form of pancreatic cancer - Scripps News
FDA approves first-of-its-kind treatment for most common form of pancreatic cancer Scripps News